CCS
MXL icon

Crosspoint Capital Strategies’s MaxLinear MXL Stock Holding History

Crosspoint Capital Strategies’s Portfolio MXL Stock Details MXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-457
Closed -$9K – 162
2016
Q3 		$9K Hold
457
– – 0.01% 65
2016
Q2 		$8K Buy
+457
New +$8.48K 0.01% 76

Other funds holding MXL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Crosspoint Capital Strategies's MXL Position: Q4 2016 in Review

Crosspoint Capital Strategies sold out of MaxLinear (MXL) in Q4 2016, closing a stake of 457 shares — an estimated $9K sold.

Crosspoint Capital Strategies first reported a position in MXL in Q2 2016 and held it in 2 quarters. The position peaked at $9K in Q3 2016. 195 funds tracked by Wall St. Rank hold MXL as of Q4 2016.

  • Crosspoint Capital Strategies reported no remaining MaxLinear position as of Q4 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 457 MaxLinear shares in Q4 2016, an estimated $9K.
  • Crosspoint Capital Strategies first reported a position in MaxLinear in Q2 2016 and held it in 2 quarters.
  • Crosspoint Capital Strategies's MaxLinear position peaked at $9K in Q3 2016.
  • 195 funds tracked by Wall St. Rank held MaxLinear as of Q4 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2016, filed 23 Jan 2017.